Lessons of the pandemic loom large in EU’s pharmaceutical strategy. ‘Never again do we want to see the problems we faced in the first weeks of the crisis,’ says EU vice president Margaritis Schinas

Freedom of information request shows Biomedical Catalyst is backing only 4% of applications assessed as worthy of funding

Strict EU data protection rules are obstructing the sharing of medical data and blocking research

Shadow industrial strategy minister tells Science|Business she has doubts about proposed new funding agency and says it will be ‘a failure’ if UK doesn’t participate in future EU research programmes

Pierre Larrouturou wants member states to agree new financial transaction tax that he says would raise €50B per annum to boost EU budgets for health, research and climate programmes that are essential to pandemic recovery

Cutting the health budget from €10B to €2B will leave little money for Europe’s Beating Cancer plan, claim MEPs. But health commissioner Stella Kyriakides says funding will come from a range of sources

As global warming threatens to undermine advances in human health, experts at the World Health Summit call for sustainable, carbon-neutral farming practices

The European Commission has put forward a calendar of policy initiatives for 2021, putting flesh on the proposal to set up a biomedical research modelled on the US Biomedical Advanced Research and Development Authority

US biomedical research body has seen its role grow during the pandemic but has found itself in dispute with the US president. ‘Trump was forced on BARDA, not the other way around’, says one observer